Hims & Hers Health (NYSE:HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A message at the top of Apostrophe's website says, "Apostrophe is being discontinued ...
(Reuters) -Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to "simplify its (company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results